 Ida Franiak-pietryga
|
|
| Title(s) | SRA 1, Radiation Medicine and Applied Science |
|---|
| School | Vc-health Sciences-schools |
|---|
| Address | 9500 Gilman Drive #
La Jolla CA 92093
|
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL. Toxicol Appl Pharmacol. 2020 Sep 15; 403:115139.
Franiak-Pietryga I, Ziemba B, Sikorska H, Jander M, Kuncman W, Danilewicz M, Appelhans D, Lewkowicz P, Ostrowska K, Bryszewska M, Borowiec M. PMID: 32687837.
View in: PubMed Mentions: Fields:
-
B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Clin Cancer Res. 2020 Jul 01; 26(13):3345-3359.
Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. PMID: 32193227.
View in: PubMed Mentions: 2 Fields:
-
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia. Anticancer Agents Med Chem. 2020; 20(3):325-334.
Ziemba B, Sikorska H, Jander M, Kuncman W, Danilewicz M, Appelhans D, Bryszewska M, Borowiec M, Franiak-Pietryga I. PMID: 31738155.
View in: PubMed Mentions: Fields:
-
Affecting NF-?B cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles. Toxicol Appl Pharmacol. 2018 10 15; 357:33-38.
Franiak-Pietryga I, Ostrowska K, Maciejewski H, Ziemba B, Appelhans D, Voit B, Jander M, Trelinski J, Bryszewska M, Borowiec M. PMID: 30125597.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Blockage of Wnt/ß-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study. Macromol Biosci. 2017 11; 17(11).
Franiak-Pietryga I, Maciejewski H, Ziemba B, Appelhans D, Voit B, Robak T, Jander M, Trelinski J, Bryszewska M, Borowiec M. PMID: 28762636.
View in: PubMed Mentions: 2 Fields: Translation: HumansCells
-
Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays. Anticancer Agents Med Chem. 2017; 17(1):102-114.
Franiak-Pietryga I, Ziólkowska E, Ziemba B, Appelhans D, Maciejewski H, Voit B, Kaczmarek A, Robak T, Klajnert-Maculewicz B, Cebula-Obrzut B, Smolewski P, Borowiec M, Bryszewska M. PMID: 27349446.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells. Macromol Biosci. 2017 05; 17(5).
Franiak-Pietryga I, Ostrowska K, Maciejewski H, Appelhans D, Misiewicz M, Ziemba B, Bednarek M, Bryszewska M, Borowiec M. PMID: 27996200.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway. Int J Biol Macromol. 2016 Jul; 88:156-61.
Franiak-Pietryga I, Maciejewski H, Ostrowska K, Appelhans D, Voit B, Misiewicz M, Kowalczyk P, Bryszewska M, Borowiec M. PMID: 26987432.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer. Int J Pharm. 2014 Jan 30; 461(1-2):391-402.
Ziemba B, Franiak-Pietryga I, Pion M, Appelhans D, Muñoz-Fernández MÁ, Voit B, Bryszewska M, Klajnert-Maculewicz B. PMID: 24361266.
View in: PubMed Mentions: 3 Fields: Translation: HumansCells
-
The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI. Mol Pharm. 2013 Jun 03; 10(6):2490-501.
Franiak-Pietryga I, Ziólkowska E, Ziemba B, Appelhans D, Voit B, Szewczyk M, Góra-Tybor J, Robak T, Klajnert B, Bryszewska M. PMID: 23641871.
View in: PubMed Mentions: 2 Fields: Translation: HumansCells
-
Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases. Cancer Biol Ther. 2013 Jan; 14(1):6-12.
Rogalinska M, Franiak-Pietryga I, Blonski JZ, Góralski P, Maciejewski H, Janus A, Robak P, Mirowski M, Piekarski H, Robak T, Kilianska ZM. PMID: 23114648.
View in: PubMed Mentions:
-
Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro. Postepy Hig Med Dosw (Online). 2012 Oct 22; 66:730-8.
Ziólkowska E, Franiak-Pietryga I, Cebula-Obrzut B, Blonsk JZ, Robak T, Smolewski P, Korycka-Wolowiec A. PMID: 23175327.
View in: PubMed Mentions: Fields: Translation: HumansCells
-
Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results. Leuk Res. 2012 Sep; 36(9):1134-40.
Franiak-Pietryga I, Maciejewski H, Wolowiec D, Salagacka A, Blonski JZ, Janus A, Kotkowska A, Wawrzyniak E, Ghia P, Mirowski M, Robak T, Korycka-Wolowiec A. PMID: 22608309.
View in: PubMed Mentions: Fields: Translation: HumansCTClinical Trials
-
Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study. Pharmacol Rep. 2012; 64(2):412-20.
Franiak-Pietryga I, Salagacka A, Maciejewski H, Blonski JZ, Borowiec M, Mirowski M, Robak T, Korycka-Wolowiec A. PMID: 22661193.
View in: PubMed Mentions: 2 Fields: Translation: HumansCells
-
Anti-inflammatory and hypolipemic effects in vitro of simvastatin comparing to epicatechin in patients with type-2 hypercholesterolemia. Food Chem Toxicol. 2009 Feb; 47(2):393-7.
Franiak-Pietryga I, Koter-Michalak M, Broncel M, Duchnowicz P, Chojnowska-Jezierska J. PMID: 19084570.
View in: PubMed Mentions: 4 Fields: Translation: HumansCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2008 | 1 | | 2012 | 4 | | 2013 | 2 | | 2016 | 2 | | 2017 | 2 | | 2018 | 1 | | 2020 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|